Altered Gut Microbiota and Host Metabolite Profiles in HIV-infected Women.
Alterations in gut microbiota (GMB) and host metabolites have been noted in HIV-infected individuals. However, it remains unclear whether alterations in GMB and related functional groups may contribute to disrupted host metabolite profiles in HIV-infected individuals. This study included 185 women (128 with long-standing HIV infection, 88% under antiretroviral therapy; and 57 HIV-uninfected from the same geographic location with comparable characteristics). Stool samples were analyzed by 16S rRNA V4 region sequencing, and GMB function was inferred by PICRUSt. Plasma metabolomic profiling was performed using liquid chromatography tandem mass spectrometry, and133 metabolites (amino acids, biogenic amines, acylcarnitines and lipids) were analyzed. Four predominant bacterial genera were identified to be associated with HIV infection, with higher abundances of Ruminococcus and Oscillospira and lower abundances of Bifidobacterium and Collinsella in HIV-infected women compared to HIV-uninfected women. HIV-infected women showed a distinct plasma metabolite profile, featured with elevated glycerophospholipid levels, compared to HIV-uninfected women. Functional analyses also indicated that GMB lipid metabolism was enriched in HIV-infected women. Ruminococcus and Oscillospira were among the top bacterial genera that contribute to the GMB glycerophospholipid metabolism pathway and showed positive correlations with host plasma glycerophospholipid levels. One bacterial functional capacity in the acetate and propionate biosynthesis pathway was identified to be mainly contributed by Bifidobacterium, and this functional capacity was lower in HIV-infected women than that in HIV-uninfected women. Our integrative analyses identified altered gut microbiota with related functional capacities that might be associated with disrupted plasma metabolite profiles in HIV-infected women.